Published: 29-04-2021
Framing genetic engineering as ‘natural’ fuels conflict and creates distractions in the discussions about the technology, says Jack Heinemann – including those around the newly commercialised techniques of genome editing and gene silencing.
Published: 16-03-2021
A new policy briefing from the Genome Editing and Agriculture: Policies, Practices and Public Perceptions (GEAP3) project discusses choices and dilemmas facing policy makers and societal stakeholders in the European Union and the United Kingdom asks bigger questions.
Published: 16-11-2020
In September of this year, the first-ever public detection method for a gene-edited crop was announced. The new method detects a herbicide-tolerant (SU) rapeseed variety that was developed using gene […]
Published: 02-06-2020
Reclaiming a baseline of accountability is the first step in building public confidence in regulatory systems that work for people as well as science that the public believes in.
Published: 24-03-2020
A new report suggests that while plant breeders of all kinds support the idea of ‘working together’ – there are few practical or regulatory pathways for achieving ‘co-existence’
Published: 10-01-2020
We need an active public debate on the ethics of gene editing technology to realise its potential and prevent it being used in nefarious ways.
Published: 20-12-2019
As the UK prepares to leave the EU vast amounts of legislation are being transferred, via Statutory Instruments (SIs), from EU law to the UK. Amongst these are regulations relating […]
Published: 28-08-2019
Following our panel discussion ‘Can Organic GMOs ever be a ‘thing’? held at Natural and Organic Products Europe in London in April, two of our panellists continued their discussion and […]
Published: 21-06-2019
This week an unusually diverse group of stakeholders gathered together to discuss a rapidly developing issue in animal agriculture – gene edited livestock. The day-long roundtable meeting, which was co-hosted […]
Published: 18-03-2019
A group of 18 scientists and bioethicists from seven countries has called for a “global moratorium” on all clinical uses of human germline editing to ‘re-engineer’ humans.
